IND approval for PII Stem Cell Trial for Stroke, Aldargen
January 6th, 2011
No comments
The FDA has accepted Aldargen’s IND application to start phase II clinical trials for stroke patients. Read more…
Categories: Aldargen, PII clinical trial for stroke, Stem Cell Technology
